191 related articles for article (PubMed ID: 27364686)
1. Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types.
Ren S; Zhang Z; Xu C; Guo L; Lu R; Sun Y; Guo J; Qin R; Qin W; Gu J
Cell Res; 2016 Aug; 26(8):963-6. PubMed ID: 27364686
[No Abstract] [Full Text] [Related]
2. Causal link between immunoglobulin G glycosylation and cancer: A potential glycobiomarker for early tumor detection.
Wang J; Huang C; Zhou J; Zhao K; Li Y
Cell Immunol; 2021 Mar; 361():104282. PubMed ID: 33453507
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis.
Saldova R; Wormald MR; Dwek RA; Rudd PM
Dis Markers; 2008; 25(4-5):219-32. PubMed ID: 19126966
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G galactosylation deficiency determined by isoelectric focusing and lectin affinoblotting in differential diagnosis of rheumatoid arthritis.
Kötz K; Hänsler M; Sauer H; Kaltenhäuser S; Häntzschel H
Electrophoresis; 1996 Mar; 17(3):533-4. PubMed ID: 8740175
[TBL] [Abstract][Full Text] [Related]
5. Serial changes in the galactosylation of autoantibodies and serum IgG in autoimmune haemolytic anaemia.
Barker RN; Leader KA; Elson CJ
Autoimmunity; 1999 Oct; 31(2):103-8. PubMed ID: 10680748
[TBL] [Abstract][Full Text] [Related]
6. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
7. IgG1 Fc N-glycan galactosylation as a biomarker for immune activation.
de Jong SE; Selman MH; Adegnika AA; Amoah AS; van Riet E; Kruize YC; Raynes JG; Rodriguez A; Boakye D; von Mutius E; Knulst AC; Genuneit J; Cooper PJ; Hokke CH; Wuhrer M; Yazdanbakhsh M
Sci Rep; 2016 Jun; 6():28207. PubMed ID: 27306703
[TBL] [Abstract][Full Text] [Related]
8. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation.
Matsumoto A; Shikata K; Takeuchi F; Kojima N; Mizuochi T
J Biochem; 2000 Oct; 128(4):621-8. PubMed ID: 11011144
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of serum IgG galactosylation assists differential diagnosis of ovarian cancer.
Qian Y; Wang Y; Zhang X; Zhou L; Zhang Z; Xu J; Ruan Y; Ren S; Xu C; Gu J
J Proteome Res; 2013 Sep; 12(9):4046-55. PubMed ID: 23855414
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes.
Perdivara I; Peddada SD; Miller FW; Tomer KB; Deterding LJ
J Proteome Res; 2011 Jul; 10(7):2969-78. PubMed ID: 21609021
[TBL] [Abstract][Full Text] [Related]
12. Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.
Clark D; Mao L
Dis Markers; 2012; 33(1):1-10. PubMed ID: 22710864
[TBL] [Abstract][Full Text] [Related]
13. Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases.
Zhang D; Chen B; Wang Y; Xia P; He C; Liu Y; Zhang R; Zhang M; Li Z
Sci Rep; 2016 May; 6():25957. PubMed ID: 27173519
[TBL] [Abstract][Full Text] [Related]
14. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
[No Abstract] [Full Text] [Related]
15. Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer.
Grassadonia A; Tinari N; Natoli C; Yahalom G; Iacobelli S
Dis Markers; 2013; 35(6):747-52. PubMed ID: 24347795
[TBL] [Abstract][Full Text] [Related]
16. Changes in the galactose content of IgG during humoral immune responses.
Lastra GC; Thompson SJ; Lemonidis AS; Elson CJ
Autoimmunity; 1998; 28(1):25-30. PubMed ID: 9754811
[TBL] [Abstract][Full Text] [Related]
17. Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.
Dekkers G; Rispens T; Vidarsson G
Front Immunol; 2018; 9():553. PubMed ID: 29616041
[TBL] [Abstract][Full Text] [Related]
18. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
19. 'Liquid biopsy' for cancer promises early detection.
Kaiser J
Science; 2018 Jan; 359(6373):259. PubMed ID: 29348215
[No Abstract] [Full Text] [Related]
20. IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis.
Lundström SL; Hensvold AH; Rutishauser D; Klareskog L; Ytterberg AJ; Zubarev RA; Catrina AI
Arthritis Res Ther; 2017 Aug; 19(1):182. PubMed ID: 28793911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
